Editas Medicine
World Rank (Jan-05-2024)
9,928
Market Cap (Jan-05-2024)
0.779 Billion USD
World Rank (Jul-30-2023)
10,632
Market Cap (Jul-30-2023)
0.707 Billion USD
World Rank (Dec-25-2022)
11,186
Market Cap (Dec-25-2022)
0.608 Billion USD
World Rank (Jan-07-2022)
6,883
Market Cap (Jan-07-2022)
1.72 Billion USD
Annual Revenue in USD
20 Million USD
Annual Net Income in USD
-220 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Editas Medicine is a Biotechnology company. It is a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. The company discover, develop, manufacture, and commercialize transformative, durable and precise genomic medicines for a broad class of diseases. The headquarters is in USA.
Company Website